Drug Search Results
Using advanced filters...
Advanced Search [+]

Serrapeptase

Alternative Names: serrapeptase, serratiopeptidase
Clinical Status: Inactive
Latest Update: 2024-06-25
Latest Update Note: News Article

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Chile | Dominican Republic | Ecuador | Germany | Greece | Hong Kong | India | Italy | Jordan | Korea | Lebanon | Malaysia | Mexico | Morocco | Pakistan | Peru | Portugal | Taiwan | Ukraine | United Arab Emirates | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Hayat
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 4: Trismus|Inflammation

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

Ser.01

P4

Unknown status

Inflammation|Trismus

2016-01-01

2019-03-20